About Aranda
A cross-disciplinary company built to solve one of global health’s most intractable challenges.
Aranda is building a new operating model for antimicrobial access.
Our organisation was founded on a simple conviction: the world does not only need new antibiotics. It also needs a way to ensure that the right medicines reach the right patients, in the right places, at the right time – and that they are used appropriately once they get there.
That requires more than R&D and procurement. It requires supply, surveillance, stewardship, financing, clinical delivery, government adoption, and economic alignment, to work as one system.
Aranda brings those pieces together in a fixed-price national subscription service that governments can buy, manufacturers can participate in, and health systems can execute.
The result: lowered costs, immediate improvements in health outcomes, and conditions established to underpin longer-term independence from donor funding.
Where we are
After three years of partnership and joint development with a government in southern Africa, Aranda is preparing for global launch.
Additional countries are in active development. Our approach is designed to scale yet be totally driven by specific country needs and conditions – the service is designed in partnership at a country level.
Each subsequent implementation strengthens the next: country design is financed by Aranda, while the resulting service generates surpluses that fund design of future countries.
Who we are
Aranda is led by a team with deep experience across government, pharmaceuticals, global health, finance, and emerging market delivery.
That cross-disciplinary foundation is central to the model. Antimicrobial access and resistance issues have been studied and debated for decades, but no single field has been able to solve it alone. Aranda brings the required disciplines together under one accountable, viable structure.
CONNECT WITH US
Aranda is building an economically-viable approach to solving one of global health’s most urgent and intractable problems.